Neuro, I hope you aren't attacking me for inquiring about the HI's and CX-701 for Vet medicine. I wasn't complaining at all--I was genuinely curious (I've actually asked many times about the RD/Vet medicine progress, but received no response).
Thanks to your input, I am learning to temper my frustration and consider the many angles/working parts that involve drug development. I hope you have been enlightened from time to time on this board also. I can tell by your defensive stance, you too are frustrated....
If you could shed any light on; a) Cor's stance on Vet medicine (with CX-701 or others), and; b) Whether, for survival purposes, a HI deal for maybe 10-15 mill. upfront (but mostly back-loaded with good milestones), is something Cor is or should be considering?
News 
Market Data 
Discover 
AI
